NCT00656903
High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration No drug interventions Not Available Not Available completed NCT00101764
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders treatment 1 completed NCT00078221
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) No drug interventions treatment 3 unknown_status NCT04008121
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium diagnostic 0 not_yet_recruiting NCT00804921
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab Not Available 2 completed NCT00150202
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) treatment 3 completed NCT00492284
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) treatment 2 completed NCT00996684
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration treatment 2 unknown_status NCT01653184
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration No drug interventions treatment Not Available completed NCT00722384
Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 treatment 1 completed NCT00896779
Lucentis in Advanced Macular Degeneration treatment 2 completed NCT00050479
Laser and Medical Treatment of Diabetic Macular Edema treatment 3 completed NCT03732287
Cooling Anesthesia for Intravitreal Injection No drug interventions treatment 1 / 2 completed NCT01245387
Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration Not Available Not Available completed NCT00385333
Metabolic Mapping to Measure Retinal Metabolism No drug interventions diagnostic 2 completed NCT02540954
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) treatment 3 completed NCT06224751
Developing Better Computerised Vision Tests (CVTV) No drug interventions Not Available Not Available recruiting NCT04658251
Study of New Mutations in Cone Disorders No drug interventions Not Available Not Available recruiting NCT00727753
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD) Not Available Not Available completed NCT00436553
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization treatment 3 completed NCT00308477
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion treatment 1 / 2 completed NCT02390245
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study No drug interventions other Not Available completed NCT00000145
Age-Related Eye Disease Study (AREDS) No drug interventions treatment 3 completed NCT01024998
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) No drug interventions treatment 1 completed NCT02659098
A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy treatment 2 completed NCT00426998
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD treatment 2 completed NCT00220805
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration treatment 2 completed NCT01494805
Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration No drug interventions treatment 1 / 2 completed NCT00041483
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD treatment 3 completed NCT00065728
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD treatment 3 terminated NCT05100511
Fundus Image-guided Focal Electroretinography, Usability Study No drug interventions other Not Available completed NCT00570193
Photodynamic and Pharmacologic Treatment of CNV treatment 1 / 2 completed NCT03846193
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD No drug interventions treatment 1 / 2 terminated NCT00320788
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) treatment 2 completed NCT00121407
Visudyne® in Occult (VIO) treatment 3 completed NCT00100009
Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration treatment 3 completed NCT03946085
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD) No drug interventions prevention Not Available completed NCT05130385
High Resolution Optical Coherence Tomography No drug interventions Not Available Not Available recruiting NCT00008515
Fluocinolone Implant to Treat Macular Degeneration treatment 1 completed NCT02895815
Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) treatment 2 withdrawn NCT00102115
Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease treatment 1 terminated NCT00877032
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration No drug interventions prevention 1 completed NCT02420132
Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) No drug interventions Not Available Not Available completed NCT03335852
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD treatment 1 completed NCT00000152
Randomized Trial of Beta-Carotene and Macular Degeneration prevention 3 unknown_status NCT01933152
Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration Not Available Not Available completed NCT00465400
Oxidative Stress in Patients With Age-Related Macular Degeneration No drug interventions Not Available Not Available completed NCT05439759
Factors in Learning And Plasticity: Healthy Vision No drug interventions basic_science Not Available recruiting NCT02313259
The Impact of Ocular Diseases on Driving: a Prospective Study No drug interventions Not Available Not Available completed NCT00320775
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD treatment 1 completed NCT00527475
Ranibizumab and Reduced Fluence PDT for AMD treatment 2 completed NCT01746875
A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes prevention Not Available terminated NCT00327470
An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD treatment 4 terminated NCT00403442
Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD No drug interventions treatment 1 terminated NCT04428242
Study Evaluating Retinal Health Monitoring System Thickness Module No drug interventions Not Available Not Available withdrawn NCT03804099
Effect Aflibercept on Ocular Perfusion treatment 4 completed NCT00414999
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers treatment 1 completed NCT00414206
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) treatment 2 terminated NCT02941406
MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients No drug interventions Not Available Not Available unknown_status NCT00523406
Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) No drug interventions treatment 3 completed NCT01339949
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV) No drug interventions treatment Not Available withdrawn NCT03539549
A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) treatment 2 completed NCT04640649
Prediction of Progression of Age-Related Macular Degeneration No drug interventions diagnostic Not Available unknown_status NCT00531336
MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen treatment 2 completed NCT00021736
Phase II/III Study of Anti-VEGF in Neovascular AMD treatment 2 / 3 completed NCT02067013
Analysis of Aqueous and Vitreous Humor basic_science 2 unknown_status NCT00668213
Antioxidant Systems and Age-Related Macular Degeneration No drug interventions Not Available Not Available completed NCT02689518
EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection treatment 4 completed NCT02225119
The Focal Electro-Oculogram in Macular Disease No drug interventions Not Available Not Available completed NCT03411941
Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) Not Available Not Available completed NCT00531141
The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study No drug interventions Not Available Not Available completed NCT03011541
Stem Cell Ophthalmology Treatment Study II No drug interventions treatment Not Available recruiting NCT02332941
Treatment -Resistant Neovascular Age-Related Macular Degeneration treatment 1 completed NCT05675917
MacuTest Website for Personalized AMD Risk Prediction and Prevention No drug interventions prevention Not Available withdrawn NCT02749734
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases No drug interventions treatment 1 / 2 unknown_status NCT00559234
Potential Research Participants for Future Studies of Inherited Eye Diseases No drug interventions Not Available Not Available completed NCT05454124
Factors in Learning And Plasticity: Macular Degeneration No drug interventions basic_science Not Available recruiting NCT04685824
Visual Telerehabilitation in AMD Patients No drug interventions supportive_care Not Available terminated NCT00531024
Systemic Avastin Therapy in Age-Related Macular Degeneration treatment 2 / 3 completed NCT04714424
Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues No drug interventions Not Available Not Available completed NCT02868424
Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation No drug interventions treatment 0 unknown_status NCT00324116
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions treatment 4 completed NCT02615496
Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept No drug interventions Not Available Not Available completed NCT00032396
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration treatment 2 unknown_status NCT02686658
Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration treatment 2 / 3 completed NCT00976235
A Long-Term Monitoring Study of the IMT-002 Patients No drug interventions other Not Available completed NCT00087763
Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) treatment 2 completed NCT02462486
Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration treatment 3 completed NCT01783925
Eylea Post Marketing Surveillance(PMS) Not Available Not Available completed NCT00784225
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 prevention 3 completed NCT03815825
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 completed NCT00089830
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration treatment 2 terminated NCT01756248
EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan Not Available Not Available completed NCT00509548
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD treatment 2 terminated NCT01362348
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) treatment 2 terminated NCT01521065
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration No drug interventions treatment 2 unknown_status NCT01115231
Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration No drug interventions Not Available Not Available completed NCT06074731
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography No drug interventions Not Available Not Available recruiting NCT02032173
Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase treatment 3 terminated NCT01632527
Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) No drug interventions treatment 1 / 2 completed NCT00071227
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders treatment 1 completed NCT00157976
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration treatment 3 unknown_status NCT00058994
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD treatment 3 completed NCT04684394
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration treatment 2 terminated NCT00813891
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration treatment 4 unknown_status NCT04141891
Advancing Understanding of Transportation Options No drug interventions health_services_research Not Available completed NCT00000162
Branch Vein Occlusion Study No drug interventions treatment 3 completed NCT00043680
Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy treatment 2 completed NCT00454389
A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration treatment 3 unknown_status NCT01655589
VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents No drug interventions Not Available Not Available unknown_status NCT01748292
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab treatment 3 completed NCT00769392
Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection treatment Not Available completed NCT00041444
Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study No drug interventions Not Available Not Available completed NCT01920867
Stem Cell Ophthalmology Treatment Study No drug interventions treatment Not Available unknown_status NCT05571267
Safety Study of Zimura™in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD treatment 2 terminated NCT00000167
Complications of Age-Related Macular Degeneration Prevention Trial No drug interventions prevention 3 completed NCT00733304
An Extension to Study MD7108240 treatment 2 completed NCT02181504
A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration treatment 2 completed NCT04270604
Biological Sample Collection for Research and Biobanking No drug interventions Not Available Not Available terminated NCT04111068
Improving Vision in Adults With Macular Degeneration No drug interventions treatment Not Available completed NCT04762368
Learning Study: Improving Vision in Adults With Macular Degeneration No drug interventions treatment Not Available recruiting NCT02747368
Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration No drug interventions screening Not Available unknown_status NCT02558712
Technology-based Eye Care Services (TECS) Compare No drug interventions diagnostic Not Available completed NCT05456581
Scotoma Perimetry Oculomotor Training No drug interventions basic_science Not Available recruiting NCT00001395
Long Term Follow-Up of Diabetic Retinopathy No drug interventions Not Available Not Available completed NCT06583395
Quest to Analyze One Thousand Humans Meditating No drug interventions Not Available Not Available enrolling_by_invitation NCT03521895
An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies Not Available Not Available completed NCT01134055
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration treatment 2 completed NCT05637255
A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD) No drug interventions treatment 2 recruiting NCT00659555
Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops treatment 1 completed NCT00000150
Submacular Surgery Trials (SST) No drug interventions treatment 3 completed NCT00090623
A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) treatment 3 completed NCT02264938
Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation No drug interventions prevention Not Available completed NCT00538538
Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) treatment 1 withdrawn NCT00735943
Macugen Observational Study No drug interventions Not Available Not Available terminated NCT00605943
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab No drug interventions Not Available Not Available completed NCT04567303
Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration treatment 1 / 2 recruiting NCT00343603
Tracking Optical Coherence Tomography No drug interventions Not Available Not Available completed NCT04499703
Evaluation of the Retinal Health Monitoring System Thickness Module No drug interventions Not Available Not Available completed NCT03470103
A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America Not Available Not Available completed NCT00499590
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD treatment 3 terminated NCT03603990
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema No drug interventions treatment Not Available withdrawn NCT00359164
Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. treatment 2 completed NCT00006202
Lutein for Age-Related Macular Degeneration treatment 2 completed NCT02486484
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection treatment 2 unknown_status NCT00100087
Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System No drug interventions treatment 1 / 2 unknown_status NCT00095433
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) treatment 3 completed NCT00001733
Screening for Studies on Retinovascular Diseases No drug interventions Not Available Not Available completed NCT01773954
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration treatment Not Available completed NCT00447954
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration treatment 2 completed NCT02090751
Development of a Device to Measure Dark Adaptation No drug interventions Not Available Not Available completed NCT00312351
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) treatment 4 terminated NCT00259753
Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration treatment 2 completed NCT00684853
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD treatment 2 unknown_status NCT00637377
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) treatment 3 completed NCT02157077
Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration treatment 3 completed NCT01831947
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. treatment 4 completed NCT02821247
Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece Not Available Not Available completed NCT03956797
Long Term Safety of Cooling Anesthesia for Intravitreal Injection No drug interventions treatment Not Available completed NCT01756261
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan Not Available Not Available completed NCT00000161
Randomized Trials of Vitamin Supplements and Eye Disease prevention 3 unknown_status NCT02462928
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration treatment 3 completed NCT00239928
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration treatment 2 completed NCT00042211
Preventing Depression in Patients With Macular Degeneration No drug interventions prevention 3 completed NCT00745511
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) treatment 1 / 2 unknown_status NCT02827071
Ocular Imaging Study Using Advanced OCT No drug interventions Not Available Not Available unknown_status NCT04988178
Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann. No drug interventions Not Available Not Available completed NCT02222207
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration treatment 2 terminated NCT00395707
Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration treatment 1 / 2 completed NCT00299507
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) treatment 3 completed NCT03105609
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging No drug interventions Not Available Not Available terminated NCT01021956
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD No drug interventions treatment 2 terminated NCT00612456
To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD treatment 2 completed NCT02087085
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration treatment 2 terminated NCT00001615
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration No drug interventions treatment 1 completed NCT06262737
Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol No drug interventions Not Available Not Available recruiting NCT01025232
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) treatment 1 / 2 terminated NCT06394232
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. treatment 1 / 2 recruiting NCT06198452
Vision Improvement for Patients With Age-Related Macular Degeneration No drug interventions treatment Not Available not_yet_recruiting NCT00469352
A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD treatment 3 completed NCT06511700
Implementation of the Intravitreal Injection Administered by Nurses No drug interventions Not Available Not Available not_yet_recruiting NCT01600300
Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration No drug interventions treatment 1 / 2 completed NCT01051700
A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans supportive_care 1 completed NCT03805100
Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD treatment 3 completed NCT02348359
X-82 to Treat Age-related Macular Degeneration treatment 2 terminated NCT00018070
Identification and Treatment of Feeder Vessels in Macular Degeneration No drug interventions treatment 1 completed NCT00109499
Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) No drug interventions treatment 1 completed NCT06203106
NYSCF Scientific Discovery Biobank No drug interventions Not Available Not Available recruiting NCT00060749
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy treatment 1 completed NCT00709449
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects treatment 2 / 3 completed NCT03318549
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases No drug interventions diagnostic Not Available completed NCT00444249
Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin No drug interventions diagnostic Not Available terminated NCT00056836
A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration treatment 3 completed NCT00926913
Investigating Optical and Neural Causes of Vision Loss No drug interventions Not Available Not Available withdrawn NCT01189019
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration treatment 2 terminated NCT00658619
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) treatment 2 completed NCT01204541
A Single-Center Pilot Study to Assess Macular Function No drug interventions Not Available Not Available completed NCT05283941
Pistachios and Neural Macular Pigment No drug interventions prevention Not Available recruiting NCT05839041
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 2 recruiting NCT03133117
Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma) No drug interventions basic_science Not Available terminated NCT02181517
A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration treatment 2 completed NCT00433017
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) treatment 2 / 3 terminated NCT00536016
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD treatment 1 completed NCT06305416
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema treatment 3 recruiting NCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study No drug interventions Not Available Not Available recruiting NCT00000158
Macular Photocoagulation Study (MPS) No drug interventions treatment 3 unknown_status NCT00211458
Treatment of Age-Related Macular Degeneration With Anecortave Acetate treatment 2 completed NCT00467935
Scotoma Reduction in AMD Patients Treated With Ranibizumab treatment 1 / 2 completed NCT05445063
Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration No drug interventions treatment 1 recruiting NCT04741763
"Night Vision and Carotenoids" No drug interventions supportive_care Not Available completed NCT04643886
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration No drug interventions treatment 2 terminated NCT00349739
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate Not Available Not Available no_longer_available NCT00478530
The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram No drug interventions treatment Not Available completed NCT02806830
Ocular Discomfort Assessment After Intravitreal Injections No drug interventions supportive_care Not Available completed NCT00709657
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion basic_science Not Available terminated NCT03954626
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD treatment 3 completed NCT05566626
Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera diagnostic Not Available enrolling_by_invitation NCT04246866
First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration No drug interventions treatment 1 completed NCT03725566
JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients No drug interventions other Not Available unknown_status NCT04435366
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) treatment 3 completed NCT02859766
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD treatment 1 completed NCT00533520
Evaluation of Dosing Interval of Higher Doses of Ranibizumab treatment 4 completed NCT00463320
A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. diagnostic 1 completed NCT03894020
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) No drug interventions Not Available Not Available active_not_recruiting NCT00094120
MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) treatment 2 terminated NCT00695682
Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) treatment 1 unknown_status NCT01941082
A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration treatment 1 completed NCT00447031
Combination Therapy for Neovascular Age Related Macular Degeneration treatment Not Available withdrawn NCT01016873
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD No drug interventions treatment 2 completed NCT00845273
Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration Not Available Not Available completed NCT00333476
A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration Not Available 2 terminated NCT00466076
Copaxone in Age Related Macular Degeneration treatment 2 / 3 unknown_status NCT02510794
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration treatment 2 completed NCT00061594
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration treatment 3 completed NCT01003691
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy No drug interventions treatment 1 completed NCT01749891
A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration treatment 1 / 2 completed NCT02581891
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye treatment 4 completed NCT01154062
A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration treatment 1 completed NCT01217762
Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) No drug interventions treatment 1 unknown_status NCT00242580
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib treatment 3 completed NCT00619229
Alprostadil in Maculopathy Study (AIMS) treatment 3 terminated NCT00051129
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) treatment 3 completed NCT02543229
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD treatment 1 completed NCT00708929
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? No drug interventions basic_science Not Available completed NCT00121589
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 treatment 1 completed NCT02569892
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration No drug interventions treatment Not Available completed NCT00088192
Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) treatment Not Available completed NCT05904444
The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies No drug interventions treatment Not Available completed NCT02452840
Photodynamic Therapy for PDA in NV AMD No drug interventions Not Available Not Available completed NCT01213667
Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD treatment 4 unknown_status NCT05147701
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases No drug interventions treatment 1 recruiting NCT02228304
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) treatment 1 / 2 terminated NCT00380172
Long-Term Efficacy in AMD of Rheopheresis in North America No drug interventions treatment Not Available unknown_status NCT03438669
Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients No drug interventions Not Available Not Available completed NCT00001346
Diabetic Retinopathy and Visual Function Study No drug interventions Not Available Not Available completed NCT01482910
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration) treatment 3 completed NCT04002310
A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy No drug interventions treatment 1 terminated NCT03614481
Clinical and Genetic Analyzes of Age-related Macular Degeneration No drug interventions Not Available Not Available recruiting NCT01771081
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy Not Available Not Available completed NCT00058695
Genetic Factors in Age-Related Macular Degeneration No drug interventions Not Available Not Available terminated NCT02555995
Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01) No drug interventions diagnostic Not Available completed NCT00509795
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) treatment 3 completed NCT01072214
A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers treatment 1 completed NCT00527423
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD No drug interventions treatment 2 completed NCT00460408
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration Not Available Not Available completed NCT03714308
Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. Not Available Not Available completed NCT01006538
Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) treatment 4 completed NCT01670643
Reading Performance With a Video Magnifier No drug interventions Not Available Not Available completed NCT00343746
Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging No drug interventions Not Available Not Available recruiting NCT03215576
Clinical Study of Transplanting Human Retinal Pigment Epithelial Cells for Treatment of Macular Degeneration No drug interventions treatment 1 / 2 recruiting NCT00001312
Age-Related Macular Degeneration and Cataract No drug interventions treatment Not Available completed